| pubmed-article:16059623 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C0521324 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C0244404 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C0444669 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C2347946 | lld:lifeskim |
| pubmed-article:16059623 | lifeskim:mentions | umls-concept:C0720318 | lld:lifeskim |
| pubmed-article:16059623 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:16059623 | pubmed:dateCreated | 2005-8-1 | lld:pubmed |
| pubmed-article:16059623 | pubmed:abstractText | In the CORE breast cancer trial of 4011 women continuing from MORE, the incidence of nonvertebral fractures at 8 years was similar between placebo and raloxifene 60 mg/day. CORE had limitations for assessing fracture risk. In a subset of 386 women, 7 years of raloxifene treatment significantly increased lumbar spine and femoral neck BMD compared from the baseline of MORE. | lld:pubmed |
| pubmed-article:16059623 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16059623 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16059623 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16059623 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16059623 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16059623 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16059623 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16059623 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16059623 | pubmed:issn | 0884-0431 | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:SirisEthel... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:WongMaymeM | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:StockJohn LJL | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:CummingsSteve... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:EastellRichar... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:HarrisSteven... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:GoemaereStefa... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:Diez-PerezAdo... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:KulkarniPandu... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:SongJingliJ | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:ZanchettaJose... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:QuYongmingY | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:SiddhantiSure... | lld:pubmed |
| pubmed-article:16059623 | pubmed:author | pubmed-author:Continuing... | lld:pubmed |
| pubmed-article:16059623 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16059623 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:16059623 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16059623 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16059623 | pubmed:pagination | 1514-24 | lld:pubmed |
| pubmed-article:16059623 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:meshHeading | pubmed-meshheading:16059623... | lld:pubmed |
| pubmed-article:16059623 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16059623 | pubmed:articleTitle | Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study. | lld:pubmed |
| pubmed-article:16059623 | pubmed:affiliation | Toni Stabile Osteoporosis Center, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. es27@columbia.edu | lld:pubmed |
| pubmed-article:16059623 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16059623 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16059623 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16059623 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16059623 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16059623 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16059623 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16059623 | lld:pubmed |
